Project Grant HT94252310672
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $302,228 project grant to The Regents of the University of California, San Francisco to support research on "Establishing and Overcoming the Mechanisms of Liver Metastasis-Induced Systemic Tumor Immune Tolerance and Immunotherapy Resistance in Melanoma." The 3-year grant project, running from September 30, 2023 to September 29, 2026, will investigate the biological mechanisms by...
- This Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $339,209.00 to The Regents of the University of California, San Francisco (UCSF) to establish and overcome the mechanisms of liver metastasis-induced systemic tumor immune tolerance and immunotherapy resistance in melanoma. The 3-year research project, with a start date of September 30, 2023 and completion date of September 29, 2026, will investigate biological and...
- This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $1,292,000.00 to the University of California, San Francisco (UCSF) to conduct in vivo mechanistic characterization of the angiogenic immune checkpoint in liver cancer. The research aims to transform healthcare for Service Members and the American public through innovative and impactful biomedical investigations. The 4-year research project will involve...
- This federal Project Grant award of $1,041,595.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF) on September 1, 2024. The award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, this 3-year Melanoma Research Program Team Science Award will fund innovative and...
- This $805,901 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is funding the University of California, San Francisco (UCSF) to investigate the molecular basis of cutaneous melanomas in non-Caucasian patients. The 3-year research project aims to advance scientific understanding of melanoma pathogenesis in diverse patient populations and explore new potential therapeutic approaches. As a leading academic medical center,...
- The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
- The Regents of the University of California, San Francisco will receive $564,954 under a three-year Project Grant from the Department of the Army Medical Command to identify novel therapeutic strategies for metastatic uveal melanoma through September 2025. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research that transforms military and public health care through innovative solutions for battlefield medicine and...
- This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,615,000.00 to The Regents of the University of California, San Francisco (UCSF) to conduct research aimed at "DISCOVERING TRANSCRIPTIONAL DRIVERS OF THERAPY-RESISTANT METASTATIC PROSTATE CANCER". The award period runs from May 1, 2024 to April 30, 2027. As a leading academic medical center, UCSF has a strong track record of...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $328,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2027. The award funds research on intracranial drug delivery strategies targeting skull bone marrow to generate antitumoral myeloid cell immune responses against glioblastoma. This research initiative represents UCSF's...
- The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), has awarded a $947,746 Project Grant to the Dana-Farber Cancer Institute, Inc. (DFCI) to conduct research on "IDENTIFICATION OF THE LIVER MICROENVIRONMENT THAT DRIVES UVEAL MELANOMA METASTASIS AND IMMUNITY". The 3-year grant, beginning on September 1, 2024 and ending on August 31, 2027, will enable DFCI, a non-profit cancer research center in Boston, MA, to investigate the liver...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $959,882.00 to The Regents of the University of California, San Francisco (UCSF) to establish and overcome the mechanisms of liver metastasis-induced systemic tumor immune tolerance and immunotherapy resistance in melanoma. The 3-year research project aims to investigate fundamental biological processes and develop new therapeutic approaches to enhance the effectiveness of immunotherapies for melanoma patients with liver metastases. As a leading academic medical center, UCSF will leverage its expertise in biomedical research, clinical trials, and medical innovation to advance this critical area of cancer research. The findings may lead to improved treatment options and outcomes for melanoma patients.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $959.9k | 9/19/23 |